BioSpace News Archive

Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers investigated the incidence of isoelectric electroencephalogram (EEG) events in infants and young children undergoing scheduled surgery requiring general anesthesia.

The Centers for Medicaid and Medicare Services last Friday issued their final National Coverage Decision on how hospitals will be approved to do the TAVR procedure, a less invasive valve replacement treatment that avoids open heart surgery and allows patients to resume daily life more quickly.

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed a collaborative agreement with GSK, to provide a combination of existing tests and custom test development to support certain GSK antibiotic clinical trials and new product developmen

China Jo-Jo Drugstores, Inc., a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, announced that the Company has entered into a strategic cooperation framework agreement with the Zhejiang Medical Insurance Bureau in June 2019.

Theranica Bioelectronics (Theranica), a biomedical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today the establishment of its wholly-owned subsidiary company, Theranica USA, headquartered in Montclair, NJ, and the appointment of senior executives to lead the commercialization of Nerivio.

CollaborateMD, a leading provider of cloud-based medical billing and practice management solutions, has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare.

ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO, and technology-led life sciences service provider, chose ThoughtSphere to power OneClinical Analytics, which is an intelligent digital, clinical analytics platform.

A non-steroidal, non-opioidal investigational study medication, already approved for use in Japan [Hernicore®], for those with sciatica or leg pain from a herniated lumbar disc is now being evaluated in a clinical research study in the United States, The Discovery 6603 Study.

Ingenico Group (Euronext: FR0000125346 - ING), the global leader in seamless payment, announced the introduction of the industry’s first payment solutions with antimicrobial product protection.

Real-world data from Advocate Health Care and Abbott shows prioritizing nutrition care for home health patients helped keep them out of the hospital